Announcements Trials
Browse Landscape

Phase

Phase 2 152Phase 1 102Phase 3 81Phase NA 38Phase 1/2 31Phase EARLY_PHASE1 4Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 207INDUSTRY 64NIH 2UNKNOWN 1OTHER_GOV 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Classical hematology 1

Conditions

Rectal Neoplasms 2Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Anemia 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Smoking Cessation 1Papillomavirus Infections 1Pancreatic Neoplasms 1Pain 1Neutropenia 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lymphoma 1Hypothyroidism 1Human Papillomavirus-Related Cervical Carcinoma 1Hepatitis C, Chronic 1Hepatitis C 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Fibrosis 1Fatigue 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Diabetes Mellitus 1

Interventions

pegfilgrastim 1Filgrastim 1Epoetin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × NIH × Breast Neoplasms × Clear all
NCT00030758 2013-08-07

Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer

National Cancer Institute (NCI)

Phase 4 Unknown
816 enrolled
Breast

Breast Neoplasms, Neutropenia

NCT00022386 2013-07-18

Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 4 Completed
BreastClassical hematology

Anemia, Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡